Supplied strictly for in-vitro and laboratory research. Not for human or veterinary use. By ordering, you confirm you are a qualified researcher handling these materials per applicable regulations and safe lab practice.
PT-141, also known as bremelanotide, is a melanocortin-receptor agonist derived from Melanotan II. It is investigated in research examining central nervous-system signaling pathways, with a focus on melanocortin-mediated activity in the brain.
Developed by Palatin Technologies following observations made during Melanotan II research, PT-141 differs from its predecessor by carrying a carboxyl group in place of an amide. It was investigated through clinical programs centered on melanocortin-mediated arousal signaling, positioning it as a more targeted successor within the melanocortin class.
PT-141 has been examined in receptor-pharmacology and behavioral models for MC3R and MC4R agonism and central melanocortin-pathway signaling. Compared with its structural parent, PT-141 shifts the research focus toward central melanocortin signaling rather than pigmentation, which is what distinguishes its profile. Its narrower receptor emphasis makes it a useful tool for studying MC3R and MC4R activity in the central nervous system.
Manufactured in a controlled U.S. facility under strict compounding standards.
Every batch third-party tested with HPLC and mass spectrometry.
Orders dispatched same-day from our U.S. facility.
Reach out and get a response within minutes.
Everything you need to know about our products and processes.